PSA test for prostate cancer: information for GPs

Public Health England


Each year in the UK, about 47,000 men are diagnosed with prostate cancer and a further 11,000 die from the disease. Localised prostate testing through digital rectal examination, biopsy, or prostate specific antigen (PSA) analysis can detect the early stages of prostate cancer when it is still practical to cure or slow its progress; evidence suggests that PSA screening could reduce prostate cancer-related mortality by 21%.





This Guidelines summary covers the diagnosis, management, and treatment of prostate cancer. It also includes an algorithm on PSA testing and the prostate cancer patient pathway.


Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:

  • GuidelinesinPractice.co.uk
  • Guidelines.co.uk
  • GuidelinesforNurses.co.uk


 




Need help? Email us